Heka is a pioneering fund, managed by the innovative and expert teams at Newfund, and is undoubtedly the first European fund exclusively dedicated to BrainTech. It invests in startups that improve the diagnosis, treatment, and quality of life for people affected by neurological, psychological, and psychiatric disorders, including mental illnesses, strokes, and cognitive disorders. They invest in digital therapies as well as neuroimaging tools and AI-powered solutions. With Heka, we aim to  contribute to the innovations essential for better prevention and care of these disorders. This is crucial in our societies, where these disorders now affect one in five people at some point in their lives.

‍